Final Results

Croda International PLC 28 February 2001 Wednesday, 28 February 2001 Croda International Plc Preliminary Results Announcement 2000 Croda today announces its preliminary results for the year ended 31 December 2000: Highlights £m 2000 1999 Pre-tax profit 48.4 24.8 Pre-tax profit before exceptionals for continuing operations 36.1 37.1 Dividends per share 11p 10.7p * Restructuring substantially complete * Now a focussed oleochemicals business * Oleochemicals margins 17% * Over £60m raised from disposals in last 6 months * Gearing reduced to 47% following Resins disposal * Excellent sales progress in the Americas and Asia * Good start to 2001 Commenting on the results, Chairman, Keith Hopkins, said: 'We continued to focus our business on Oleochemicals which during the nineties achieved compound growth of 7.5% in sales and 13.5% in trading profits. We substantially completed our reshaping of the business with the disposal of our Adhesives business in October 2000 and Resins in February 2001. Trading this year has started well, with results ahead of our performance last year.' For further information, please contact: Mike Humphrey, Chief Executive Tel: 07785 307786 Barbara Richmond, Group Finance Director Tel: 07767 252 627 Tom Baldock Financial Dynamics Tel: 0207 831 3113 Or visit our web site at: www.croda.co.uk where the presentation to analysts will be available by midday today. Chairman's Statement As we had expected, trading in the last six months of 2000 proved to be more difficult primarily due to the poor demand from UK manufacturing industry. Profit, before tax and exceptional items, for the year was £38.1m compared to the £40.5m we achieved last year. Turnover from continuing operations at £308m was a little ahead of last year. While sales in the UK continued to decline elsewhere useful gains were made despite the weakness of the Euro. With a higher tax charge than last year due to a decrease in the proportion of UK to overseas profits, earnings per share were 19.0p (1999 20.4p). The Board recommends a final dividend of 7.25p, an increase of 2.8% on the 7.05p paid last year, making a total of 11p for the year (1999 10.7p). The final dividend will be paid on 6 July 2001 following approval by shareholders at our AGM on 24 April 2001. Trading UK sales fell and indeed some customers moved their operations overseas. Our European operations continued to make strong progress with sales from continuing operations 9% up in local currencies. The performance in our American operations was again outstanding with further strong growth in sales and profits and a continuing flow of good opportunities for next year. In Asia sales in continuing operations rose by 13%. Overall our Oleochemical operations put in a robust performance with sales rising to £256m (1999 £249m) and operating profits moving forward to £43.4m compared with £42.3m the previous year. Operating margins were in line with those achieved in1999. Commissioning problems in our new Singapore plant held back profits but production volumes are now growing. Our Japanese operation had a record year, far exceeding last year's good performance, as sales of high value specialities from our factory in Japan grew strongly both in home and export markets. Industrial chemicals profits were particularly badly hit by the fall in UK activity. On sales down 6% at £51.5m, profits from continuing operations were a little lower at £5.5m in 2000 compared to £6m in 1999. Good progress was made in our Fire Fighting Chemical operations following their consolidation on to one UK site. A technical breakthrough in the production of fire-fighting foams is expected to lead to a strong performance in 2001. Elsewhere our associate, Baxenden Chemicals, recovered well. Corporate Development We continued to focus our business on Oleochemicals which has for many years made such good progress. Sales have grown at an annual compound rate of 7.5% during the nineties and profits at a compound rate of 13.5%. This is a world class performance and there remain many further opportunities. We continued to dispose of non-core assets and in October 2000 sold our Adhesive operations to Sovereign Specialty Chemicals for £43.3m which gave rise to an exceptional profit of £18.2m before goodwill of £7.9m is written back. In February this year we sold our Resins business to Cray Valley Ltd for £17m. The results from this business are included in discontinued operations but the surplus from the disposal will be included in our 2001 accounts. It is our intention to complete our disposal programme over the next two years and use the money to invest in and develop our core speciality chemical business. Finance Capital expenditure in 2000 was £29.6m (1999 £30.7m) compared to a depreciation charge of £14.9m (1999 £19.1m). The major spend was for our new plant in Singapore and in the UK on new ERP computer systems. The introduction of these systems into one of our UK divisions caused some initial disruption but the start of the subsequent roll-out has gone to plan. The development of our web site, croda.co.uk, and our intranet and extranet continues apace, and are being piloted with a number of major customers. Amortisation of acquired goodwill was £0.4m (1999 £0.5m). Following the disposal of Adhesives, net debt fell to £99.8m (1999 £116.9m) giving gearing of 55% at the year end and interest cover of 5.3 times. The Board 2001 will see a number of major changes to the structure of your Board. Trevor Harrison who has been a non-executive director for eight years and Chairman of the audit committee and pension fund trustees will retire at our Annual General Meeting this April. We thank him for his wise advice and the contribution he has made to the workings of the Board. Roy Fenney who has been in charge of the Industrial Chemicals sector will take early retirement at the end of March. Roy has been on the Board for 13 years and has borne the considerable task of disposing of and rationalising businesses in our reshaping of the Group. We thank him for the tireless and considerate way he has dealt with the many problems and wish him a long and happy retirement. With the focussing of the Group on Oleochemicals we have decided to reduce the size of the Board to a non-executive Chairman, Chief Executive, Finance Director and two non-executive directors. As a consequence Geoff Bull will stand down from the Board at the same time but will continue with his existing European Oleochemical responsibilities and take on from Roy the direction of our remaining businesses in Industrial Chemicals. Finally, after 25 years with the Group and in total 15 years as Chief Executive and then Chairman I will retire at the end of the year and be succeeded as Chairman by Antony Beevor who has been on the Board as a non-executive director for five years. I would like to thank all my colleagues on the Board and all the people both in and outside Croda for the help and consideration they have given me over the years. It has been both a pleasure and a privilege to lead such a fine company. People The millennium year has been a testing time for UK manufacturing and once again the Board, on behalf of our shareholders, would like to express their sincere thanks to all of our employees for the hard work and effort they have put in during the year. Outlook Although it is still early in the year trading has started well, with results ahead of our performance last year. Our vegetable oil raw materials remain at low and seemingly stable price levels and the nascent recovery in the Euro is a welcome sign for export margins. In my last year as Chairman I am certainly not going to break the habit of a lifetime and make a forecast of the outcome for the year but suffice it to say that we expect to make progress. Operating Review One can argue whether 2000 was the first year of a new millennium or the final year of the last one, but everyone would agree that it was a tough year for speciality chemicals companies in the UK. In such difficult circumstances, I am pleased to report that Croda's core Oleochemical business managed to increase both sales and profits. In our continuing Industrial Chemicals businesses, the heavy reliance on a very weak UK market led to a further fall in both sales and profits. Overall this resulted in flat sales and profits for the Group's continuing operations. Once again, Croda's North American operations produced superb results through constant innovation in marketing and product development. Double digit sales growth continued in Asia in spite of the late commissioning of the new plant in Singapore. Croda Japan had a record year in sales and profits with continued strong growth in exports of high value personal care specialities. There was a mixed picture in Europe with good growth in Mainland and Eastern Europe contrasting with a further unwelcome decline in UK sales, centred on the Industrial Chemicals operations. Sederma once again led the way in valuable new product launches and the recently established Croda Iberica produced results ahead of expectations. The drive towards a higher quality business meant that volumes were down but average prices were up. New technology plant in our Health Care business was successfully commissioned and the exciting developments in pharmaceutical products, highlighted by the long term supply agreement with Provensis, justify the many years of creative research in this area. We are well on track to meet our restructuring targets. We sold the worldwide Adhesives operations to Sovereign Specialty Chemicals and our Resins operations to Cray Valley Ltd. We consolidated our UK manufacturing by closing sites in both the Colloids and Fire Fighting businesses with no disruption to customers. Our plants now operate more efficiently and by utilising excellent technology on the key sites in these divisions they deliver more valuable capacity. The introduction of new technologies is never achieved without some heartache. This was emphasised by the late commissioning of our new plant in Singapore which was exacerbated by a series of equipment failures. I am pleased to report that the hard work and dedication of the team in Singapore is starting to pay off and the plant is now running smoothly. The implementation of new computer systems seems to have an almost mythical ability to knock companies off course. Croda has been no exception. The pilot introduction of SAP at Croda Universal gave temporary problems which reduced sales and profits in 2000. The system is now performing well. This pilot introduction enabled us to implement the new system in the more complex arena of Croda Chemicals much more effectively. The system went live in January and is performing ahead of forecast. The employees in these divisions deserve full credit for the massive effort sustained to achieve this notable success. It was a privilege to be part of this dynamic company as it celebrated 75 years of creative chemistry. 2000 was a year of major challenges and major progress as we continued to focus the business on the areas of profitable opportunity. As we strengthen the balance sheet we will seek out acquisitions to complement and enhance our position as a true speciality chemical company. Oleochemicals Results 2000 1999 £m £m External turnover 256.4 249.0 Trading profit 43.4 42.3 Capital employed 226.7 208.5 Return on capital 19.1% 20.3% In a year of many challenges, turnover grew by 3% and profits by 2.6%. The impact of SAP implementation and non-availability of capacity in Singapore held up progress. Margins were maintained as a result of product mix improvements and the shedding of higher volume, lower profit business. The Oleochemicals business continues to be of very high quality with great potential. The global distribution platform is a key to future growth and we have added to our recent successful start-ups in Spain and Argentina by opening a subsidiary in Korea. We are also in the process of buying out our partner in Mexico and establishing a wholly owned subsidiary to focus on the growth of Croda product sales in this dynamic territory. Once again the Americas led the success of the core business. In continuing businesses, turnover was a record £97.5m compared to £90.5m in 1999. Contrary to other public statements, we saw no slowdown in our main market areas of personal and home care in the fourth quarter. This quality performance was led by Croda Inc. which continued with its programme of successful new product launches. We have initiated a programme of investment in plant capacity in our core US operation to support future planned growth. We continue to increase our investment in R & D and expand the pipeline of new products created by our North American Technical Centre. Sales in Latin America grew strongly as a result of our increased focus. Sales in Asia grew by over 13% following the extremely strong growth in 1999. Most areas performed well, led by excellent sales growth in Japan, China and Singapore. The major issue in the region was the under performance of the Singapore manufacturing operation. This was a disappointment but we are confident all the significant problems are behind us. We look forward to ever increasing output throughout 2001 to meet the pent up demand. The focus on high added value specialities and an excellent team produced a record result in Japan for both turnover and profit. Sales inside Japan grew by over 20% with commensurate growth of exports through the Croda global network. The Asian economies continue to grow and as part of the regional plan we opened Croda Korea in the last quarter of 2000, which will rapidly increase our market penetration. Sales in India also grew substantially. The UK market for our Oleochemicals business was again uninspiring. The introduction of SAP into our major UK operations did cause problems and resulted in reduced profits. However, we are confident we have weathered that particular storm as evidenced by the relatively smooth roll out into Croda Chemicals in January. Prices of oleochemical raw materials, with one or two exceptions, remained benign and there are no signs of any change as we go into 2001. Growth continued in Western Europe with particularly good performances in Germany, France, Italy and Spain. Poland was once again the growth leader in our small Eastern European group. Sederma's new product 'machine' turned out more exciting molecules to increase our sales in the fast growing Actives market. Great R & D creates great products and the future looks very encouraging in both Sederma and Crodarom, our plant extracts business. Industrial Chemicals Results 2000 1999 £m £m External turnover 51.5 54.8 Trading profit 5.5 6.0 Capital employed 34.1 29.2 Return on capital 16.1% 20.5% This sector continued to suffer a weak UK market and strong competition from Eurozone based competitors. Also, it was affected much more by very firm petrochemical raw material prices. In continuing businesses, sales fell by 6.0% and profits by 8.3% mainly due to a poor performance by Celtite Australia which was somewhat offset by a recovery at our associate, Baxenden Chemicals Ltd. There was a good performance in Fire Fighting Chemicals where an exciting new product launch means we will build a small factory in the USA to complement our efficient operations in the UK and France. Application Chemicals also performed well in demanding markets. Most of the restructuring is now complete. The Adhesives operations were sold in the latter part of 2000, our Resins operations in February this year and negotiations are well advanced for the sale of our 50% share of the Croda Herberts business in Australia. Future Plans Continued investment in new productive capacity, in focussed creative R & D and the successful divestment of non-core businesses gives us a terrific platform for future profit growth. We continue to pursue value enhancing acquisitions in our key business areas and look forward to continued improvement in 2001 and beyond. Financial Review Trading The Group progressed its development into a speciality oleochemicals business with the disposal, in October 2000, of our worldwide Adhesives business to Sovereign Specialty Chemicals and in February 2001 of the worldwide Resins business to Cray Valley Ltd, part of TotalFinaElf. Whilst demand continued to grow in the core business, operational difficulties in the commissioning of the new Singapore site held back profit growth. In Oleochemicals an improvement in product mix more than offset the effect of much lower volumes of commodity products. Overall volumes in Oleochemicals were 2.5% lower. Volumes in Industrial Chemicals were down half a per cent, with competitive pressures remaining high. Currency movements continued to affect the Group in 2000 with an overall 1% positive effect on turnover. The effect on profits was, however, broadly neutral as the benefits came primarily from the translation of the results of our US subsidiary into Sterling whereas the negative effect was the transaction cost of selling UK manufactured goods in Euros. In 2000, pension costs rose substantially to £4.6m (1999: £1.2m) following the elimination of the surplus in one of our UK pension schemes. The Group also changed its estimated life for the majority of plant and equipment from 10 years to 15 years, as a consequence of which the depreciation charge for the year was reduced by £3.7m on a like for like basis. Redundancy costs were higher in 2000 at £0.9m, compared to £0.5m in 1999. Exceptional Item The only exceptional item in the 2000 results was the profit on disposal for the Adhesives business of £10.3m after the write-back of goodwill previously written off. Results from Resins are included in discontinued operations and any profit on this disposal will be included in next year's accounts. Taxation Last year I reported that we expected our tax charge to rise in 2000 due to the increasing proportion of our earnings generated overseas in countries where the corporate tax rates are higher than those in the UK. The result was an effective tax rate of 33.9% for 2000, compared with 32% in 1999. We would expect the overall rate to rise again in 2001 to between 35% and 36%. Dividend and Treasury The proposed final dividend of 7.25 pence gives a total for the year of 11 pence and dividend cover of 1.7 times. During 2000 the Group reduced net debt by £17.1m. Proceeds from the disposal of the Adhesives business amounted to £43.3m, with £41.4m received in October 2000 and the balance earlier this month. Capital expenditure on fixed assets amounted to £29.6m which was twice the depreciation charge. Subsequent to the year end we sold our Resins business and in consequence our net debt has fallen to £86m, with gearing of approximately 47%. The Group's treasury policies are approved by the Board and subject to regular reporting and review. The main financial risks faced by the Group relate to currency, interest rates and the availability of capital. As far as currency risk is concerned, transaction risk is hedged up to one month forward by the use of forward currency contracts and foreign currency bank balances. Translation currency exposure is not hedged but the risk is reduced by matching interest expense to foreign currency earnings where it is efficient to do so. The Group's borrowings are predominantly in Sterling, US Dollars and Euros. To reduce exposure to large fluctuations in interest rates, a proportion of Group debt is maintained at fixed rates. Our policy is for fixed rate debt to be less than 50% of total net debt. The proportion was 37% at the year end. Our policy is for the proportion of net debt due for repayment in the next twelve months to be below 30% and at the year end it was 13%. Employee Share Ownership During the year we continued with our policy of purchasing shares in the market as the primary means of funding our options schemes. We acquired 0.7m shares at an average price of 241p bringing the total held to five million, representing 70% of options currently outstanding. Croda International Plc, Preliminary announcement of trading results for the year ended 31 December 2000 Group profit and loss account Continuing Discontinued 2000 operations operations Total £m £m £m Turnover 307.9 58.0 365.9 _______ _______ _______ Operating profit Group operating profit 41.3 2.0 43.3 Share of associates' operating profit 3.6 - 3.6 _______ _______ _______ Total operating profit 44.9 2.0 46.9 _______ _______ Exceptional profit on disposal of discontinued operations 10.3 Net interest payable (8.8) _______ Profit before taxation 48.4 UK taxation (1.7) Overseas taxation (11.2) Tax on exceptional items (3.2) _______ Profit after taxation 32.3 Minority interests and preference dividends (0.2) _______ Profit attributable to ordinary shareholders 32.1 Ordinary dividends (14.5) _______ Reserves transfer 17.6 _______ Earnings per share Pence per share Basic 24.4 Before exceptional items 19.0 Ordinary dividends Interim 3.75 Final 7.25 Continuing Continuing Discontinued 1999 operations operations operations Total Before Exceptional exceptional items items £m £m £m £m Turnover 303.8 - 68.0 371.8 _______ _______ _______ _______ Operating profit Group operating profit 41.7 (8.3) 3.4 36.8 Share of associates 2.9 - - 2.9 operating profit _______ _______ _______ _______ Total operating profit 44.6 (8.3) 3.4 39.7 _______ _______ _______ _______ Exceptional profit on disposal of discontinued operations (7.4) Net interest payable (7.5) _______ Profit before taxation 24.8 UK taxation (3.5) Overseas taxation (9.4) Tax on exceptional items 1.4 _______ Profit after taxation 13.3 Minority interests and preference dividends (0.4) _______ Profit attributable to ordinary shareholders 12.9 Ordinary dividends (14.1) _______ Reserves transfer (1.2) _______ Earnings per share Pence per share Basic 9.7 Before exceptional items 20.4 Ordinary dividends Interim 3.65 Final 7.05 Summarised balance sheet At 31 December At 31 December 2000 1999 £m £m Fixed assets 196.9 196.4 Stock 68.7 64.1 Debtors 105.8 110.4 Creditors and provisions (91.3) (99.2) _______ _______ 280.1 271.7 _______ _______ Shareholders' funds 178.6 153.4 Minority interests 1.7 1.4 _______ _______ 180.3 154.8 Net debt 99.8 116.9 _______ _______ 280.1 271.7 _______ _______ Movement in shareholders' funds 2000 1999 £m £m Profit attributable to ordinary shareholders 32.1 12.9 Ordinary dividends (14.5) (14.1) Goodwill written back on disposal 7.9 0.4 Currency translation differences (0.3) (0.6) _______ _______ Net movement in shareholders' funds 25.2 (1.4) Opening shareholders' funds 153.4 154.8 _______ _______ Closing shareholders' funds 178.6 153.4 _______ _______ Note There were no recognised gains or losses except for those included above Summarised cash flow 2000 1999 £m £m Group pre exceptional operating profit 43.3 45.1 Depreciation 14.9 19.1 Goodwill amortisation 0.4 0.5 Working capital (11.8) (5.6) Other (2.0) (0.3) _______ _______ Operating cash flow 44.8 58.8 Interest (8.6) (7.2) Dividends paid (14.2) (9.3) Taxation (13.8) (12.2) Fixed assets purchased (29.2) (30.5) Purchase of own shares (1.8) (7.9) Disposals 41.4 0.4 Other 1.7 (1.1) _______ _______ Movement in net debt from cash flows 20.3 (9.0) New finance lease contracts (0.4) (0.2) Exchange differences (2.8) (0.3) _______ _______ Movement in net debt in the period 17.1 (9.5) _______ _______ Notes to the preliminary announcement 1. Segmental analysis of continuing operations (pre-exceptional) 2000 1999 £m £m Turnover Oleochemicals 256.4 249.0 Industrial Chemicals 51.5 54.8 _______ _______ 307.9 303.8 _______ _______ Trading profit Oleochemicals 43.4 42.3 Industrial Chemicals 5.5 6.0 _______ _______ 48.9 48.3 Central costs (4.0) (3.7) _______ _______ Operating profit 44.9 44.6 _______ _______ Turnover by geographical destination United Kingdom 64.4 71.3 Rest of Europe 82.9 81.3 Americas 97.5 90.5 Asia 36.1 31.9 Rest of World 27.0 28.8 _______ _______ 307.9 303.8 _______ _______ 2. Exceptional items before operating profit The 1999 charge related to the costs associated with consolidating the Group's production onto fewer operating sites. 3. Exceptional items after operating profit The profit on disposal of discontinued operations in 2000 of £ 10.3m relates to the disposal of the Group's worldwide Adhesives business, and is after charging goodwill written back of £7.9m. The 1999 loss principally related to the disposal and closure of the Group's Colours business and included goodwill written back of £0.4m. 4. Additional matters a. The financial information above is derived from the Group's full statutory accounts on which the auditors have reported; their reports were unqualified and did not contain a statement under section 237(2) or (3) of the Companies Act 1985. Statutory accounts for 1999 have been filed with the Registrar of Companies and those for 2000 will be delivered following the Annual General Meeting. b. The final dividend of 7.25p will be paid on 6 July 2001 to shareholders registered on 8 June 2001. c. The above financial information has been prepared on the basis of the accounting policies which are to be set out in the Group's 2000 statutory accounts, and in accordance with all applicable UK accounting standards and the Companies Act 1985. The accounting policies are consistent with those applied in previous years as set out in the Group's 1999 statutory accounts.
Investor Meets Company
UK 100